chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 57.0
Sex: M
Vaccine: COVID19
Symptoms: Erythema, Rash
Clinical narrative: rash all over his back, and chest; redness; rash all over his arm; This spontaneous case was reported by a consumer and describes the occurrence of RASH (rash all over his arm), RASH (rash all over his back, and chest) and ERYTHEMA (redness) in a 57-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 040A21A) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 02-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 02-Apr-2021, the patient experienced RASH (rash all over his arm), RASH (rash all over his back, and chest) and ERYTHEMA (redness). At the time of the report, RASH (rash all over his arm), RASH (rash all over his back, and chest) and ERYTHEMA (redness) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant product use was not provided by the reporter. Treatment information was not provided.
Age: 53.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Vaccine administered after temperature excursion; This spontaneous case was reported by an other health care professional (subsequently medically confirmed) and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Vaccine administered after temperature excursion) in a 53-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 003B21A) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No reported medical history).    On 02-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 02-Apr-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Vaccine administered after temperature excursion). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Vaccine administered after temperature excursion) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Warm Transferred from Moderna Customer Care Case No.00135704. HCP reported on 02Apr2021 that they had power outage on 02Apr2021 and vials were in Freezer and Refrigerator where Temperature dropped to : Frozen Vaccine 47Minutes -13.79 C Refrigerator 59 Minutes 12 C and effected vials are: Lot no 003B21A, 100 doses Lot no 027B21A 100 doses Lot no 030B21A 100 doses Lot No 02B21A 140 doses HCP said that 63 doses were administered to 63 Patients. She provided all requested information of patients who received the effected Vaccine.  No concomitant medications were provided.; Sender's Comments: This report refers to a case of Product Storage Error for mRNA-1273 (Lot #: 003B21A)  with no associated AEs.
Sex: F
Vaccine: COVID19
Symptoms: Body temperature fluctuation, Hypersomnia
Clinical narrative: very sleepy, and sleeping a lot; temperature seems to be going up and down; This spontaneous case was reported by a consumer and describes the occurrence of HYPERSOMNIA (very sleepy, and sleeping a lot) and BODY TEMPERATURE FLUCTUATION (temperature seems to be going up and down) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 01-Apr-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 01-Apr-2021, the patient experienced HYPERSOMNIA (very sleepy, and sleeping a lot) and BODY TEMPERATURE FLUCTUATION (temperature seems to be going up and down). At the time of the report, HYPERSOMNIA (very sleepy, and sleeping a lot) and BODY TEMPERATURE FLUCTUATION (temperature seems to be going up and down) outcome was unknown.            No relevant concomitant medications were reported. No treatment information was provided. Action taken with mRNA-1273 in response to the events was not applicable.  Upon in internal review on 21 May 2021, the age was corrected to an unknown age
Sex: F
Vaccine: COVID19
Symptoms: Injection site erythema, Injection site swelling
Clinical narrative: Red swollen and bumpy area at injection site; Red swollen and bumpy area at injection site; This spontaneous case was reported by a consumer and describes the occurrence of INJECTION SITE ERYTHEMA (Red swollen and bumpy area at injection site) and INJECTION SITE SWELLING (Red swollen and bumpy area at injection site) in a 51-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 25-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced INJECTION SITE ERYTHEMA (Red swollen and bumpy area at injection site) and INJECTION SITE SWELLING (Red swollen and bumpy area at injection site). At the time of the report, INJECTION SITE ERYTHEMA (Red swollen and bumpy area at injection site) and INJECTION SITE SWELLING (Red swollen and bumpy area at injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medication were not provided No treatment medication information were not provided
Age: 79.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: my arm is still sore; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (my arm is still sore) in a 79-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 003B21A) for COVID-19 vaccination.     Concomitant products included CARVEDILOL, RIVAROXABAN (XARELTO), LISINOPRIL, POTASSIUM and BUMETANIDE for an unknown indication.   On 31-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) at an unspecified dose. On 31-Mar-2021, the patient experienced PAIN IN EXTREMITY (my arm is still sore). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, PAIN IN EXTREMITY (my arm is still sore) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route), the reporter did not provide any causality assessments.   Action taken with mRNA-123 is not applicable.
Age: 19.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Vaccine administered after temperature excursion; This spontaneous case was reported by a health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Vaccine administered after temperature excursion) in a 19-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) at an unspecified dose. On an unknown date, the patient experienced EXPIRED PRODUCT ADMINISTERED (Vaccine administered after temperature excursion). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Vaccine administered after temperature excursion) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine), the reporter did not provide any causality assessments.
Age: 79.0
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Fatigue, Insomnia, Myalgia, Nasopharyngitis
Clinical narrative: Swollen hot arm; Cold; Cannot sleep all night; No energy; Fever; Fatigue; Aching body; This spontaneous case was reported by a consumer and describes the occurrence of PERIPHERAL SWELLING (Swollen hot arm), NASOPHARYNGITIS (Cold), INSOMNIA (Cannot sleep all night), ASTHENIA (No energy) and PYREXIA (Fever) in a 79-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. HRSO311321A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concomitant products included VITAMIN D [VITAMIN D NOS] and SALBUTAMOL SULFATE for an unknown indication.   On 01-Apr-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 2 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PERIPHERAL SWELLING (Swollen hot arm), NASOPHARYNGITIS (Cold), INSOMNIA (Cannot sleep all night), ASTHENIA (No energy), PYREXIA (Fever), FATIGUE (Fatigue) and MYALGIA (Aching body). At the time of the report, PERIPHERAL SWELLING (Swollen hot arm), NASOPHARYNGITIS (Cold), INSOMNIA (Cannot sleep all night), ASTHENIA (No energy), PYREXIA (Fever), FATIGUE (Fatigue) and MYALGIA (Aching body) outcome was unknown.            Treatment information was not provided. Action taken with mRNA-123 is not applicable.
Age: 79.0
Sex: F
Vaccine: COVID19
Symptoms: Peripheral swelling, Pyrexia
Clinical narrative: Swollen hot arm; Cold; Cannot sleep all night; No energy; Fever; Fatigue; Aching body; This spontaneous case was reported by a consumer and describes the occurrence of PERIPHERAL SWELLING (Swollen hot arm), NASOPHARYNGITIS (Cold), INSOMNIA (Cannot sleep all night), ASTHENIA (No energy) and PYREXIA (Fever) in a 79-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. HRSO311321A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concomitant products included VITAMIN D [VITAMIN D NOS] and SALBUTAMOL SULFATE for an unknown indication.   On 01-Apr-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 2 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PERIPHERAL SWELLING (Swollen hot arm), NASOPHARYNGITIS (Cold), INSOMNIA (Cannot sleep all night), ASTHENIA (No energy), PYREXIA (Fever), FATIGUE (Fatigue) and MYALGIA (Aching body). At the time of the report, PERIPHERAL SWELLING (Swollen hot arm), NASOPHARYNGITIS (Cold), INSOMNIA (Cannot sleep all night), ASTHENIA (No energy), PYREXIA (Fever), FATIGUE (Fatigue) and MYALGIA (Aching body) outcome was unknown.            Treatment information was not provided. Action taken with mRNA-123 is not applicable.
Age: 63.0
Sex: F
Vaccine: COVID19
Symptoms: Product storage error
Clinical narrative: Vaccine administered after temperature excursion; This spontaneous case was reported by a physician and describes the occurrence of PRODUCT STORAGE ERROR (Vaccine administered after temperature excursion) in a 63-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 003B21A) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 02-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 02-Apr-2021, the patient experienced PRODUCT STORAGE ERROR (Vaccine administered after temperature excursion). At the time of the report, PRODUCT STORAGE ERROR (Vaccine administered after temperature excursion) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Warm Transferred from Moderna Customer Care Case No.00135704. HCP reported on 02Apr2021 that they had power outage on 02Apr2021 and vials were in Freezer and Refrigerator where Temperature dropped to : Frozen Vaccine 47Minutes -13.79 C Refrigerator 59 Minutes 12 C and effected vials are: Lot no 003B21A, 100 doses Lot no 027B21A 100 doses Lot no 030B21A 100 doses Lot No 02B21A 140 doses HCP said that 63 doses were administered to 63 Patients. She provided all requested information of patients who received the effected Vaccine.  No concomitant medications were provided.; Sender's Comments: This report refers to a case of Product Storage Error for mRNA-1273 (Lot #: 003B21A)  with no associated AEs.
Age: 78.0
Sex: F
Vaccine: COVID19
Symptoms: Pain, Vaccination site erythema, Vaccination site swelling
Clinical narrative: FEELING ACHY; LARGE REDNESS AT INJECTION SITE; AREA AT INJECTION SITE IS SWOLLEN; This spontaneous case was reported by a consumer and describes the occurrence of PAIN, VACCINATION SITE ERYTHEMA and VACCINATION SITE SWELLING in a 78-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 31-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PAIN, VACCINATION SITE ERYTHEMA, and VACCINATION SITE SWELLING. At the time of the report, PAIN, VACCINATION SITE ERYTHEMA, and VACCINATION SITE SWELLING outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 62.0
Sex: M
Vaccine: COVID19
Symptoms: Feeling abnormal, Illness
Clinical narrative: Feeling miserable; Sick; This spontaneous case was reported by a consumer and describes the occurrence of FEELING ABNORMAL (Feeling miserable) and ILLNESS (Sick) in a 62-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 019B21A) for COVID-19 vaccination.     No Medical History information was reported.   On 03-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 01-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 01-Apr-2021, the patient experienced FEELING ABNORMAL (Feeling miserable) and ILLNESS (Sick). At the time of the report, FEELING ABNORMAL (Feeling miserable) and ILLNESS (Sick) outcome was unknown. Not Provided          Concomitant product use was not provided by the reporter. Treatment information was not provided. Action taken with mRNA-1273 in response to the events was not Applicable.
Sex: F
Vaccine: COVID19
Symptoms: Chills, Cluster headache, Diarrhoea, Dizziness, Nausea
Clinical narrative: dizziness; diarrhea; headaches; nausea; vomiting; soreness of arm; chills; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (soreness of arm), DIZZINESS (dizziness), DIARRHOEA (diarrhea), CLUSTER HEADACHE (headaches) and CHILLS (chills) in a 64-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 022M20A and 047A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event.   On 04-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 01-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 01-Apr-2021, the patient experienced PAIN IN EXTREMITY (soreness of arm) and CHILLS (chills). On 02-Apr-2021, the patient experienced DIZZINESS (dizziness), DIARRHOEA (diarrhea), CLUSTER HEADACHE (headaches), NAUSEA (nausea) and VOMITING (vomiting). The patient was treated with ACETAMINOPHEN ongoing from 02-Apr-2021 at an unspecified dose and frequency. At the time of the report, PAIN IN EXTREMITY (soreness of arm), DIZZINESS (dizziness), DIARRHOEA (diarrhea), CLUSTER HEADACHE (headaches), CHILLS (chills), NAUSEA (nausea) and VOMITING (vomiting) had not resolved.            Treatment Medication was Acetaminophen.
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity, Vomiting
Clinical narrative: dizziness; diarrhea; headaches; nausea; vomiting; soreness of arm; chills; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (soreness of arm), DIZZINESS (dizziness), DIARRHOEA (diarrhea), CLUSTER HEADACHE (headaches) and CHILLS (chills) in a 64-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 022M20A and 047A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event.   On 04-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 01-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 01-Apr-2021, the patient experienced PAIN IN EXTREMITY (soreness of arm) and CHILLS (chills). On 02-Apr-2021, the patient experienced DIZZINESS (dizziness), DIARRHOEA (diarrhea), CLUSTER HEADACHE (headaches), NAUSEA (nausea) and VOMITING (vomiting). The patient was treated with ACETAMINOPHEN ongoing from 02-Apr-2021 at an unspecified dose and frequency. At the time of the report, PAIN IN EXTREMITY (soreness of arm), DIZZINESS (dizziness), DIARRHOEA (diarrhea), CLUSTER HEADACHE (headaches), CHILLS (chills), NAUSEA (nausea) and VOMITING (vomiting) had not resolved.            Treatment Medication was Acetaminophen.
Age: 71.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Headache, Vaccination site pain
Clinical narrative: headache; Shot site painfull; Fatigue; This spontaneous case was reported by a consumer and describes the occurrence of FATIGUE (Fatigue), HEADACHE (headache) and VACCINATION SITE PAIN (Shot site painfull) in a 71-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 023M20A and 017821A) for COVID-19 vaccination.     Concomitant products included CALCIUM CARBONATE, COLECALCIFEROL (VITAMIN D 2000) for an unknown indication.   On 25-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 25-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to at an unspecified dose. On 25-Mar-2021, the patient experienced FATIGUE (Fatigue) and VACCINATION SITE PAIN (Shot site painfull). On 01-Apr-2021, the patient experienced HEADACHE (headache). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. On 25-Mar-2021, VACCINATION SITE PAIN (Shot site painfull) had resolved. At the time of the report, FATIGUE (Fatigue) and HEADACHE (headache) had not resolved.              The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was not applicable.
Age: 61.0
Sex: F
Vaccine: COVID19
Symptoms: Influenza like illness, Oropharyngeal pain
Clinical narrative: Flu like symptoms (feel warm and hot, not fever nor; Sore throat; This spontaneous case was reported by a consumer and describes the occurrence of INFLUENZA LIKE ILLNESS (Flu like symptoms (feel warm and hot, not fever nor) and OROPHARYNGEAL PAIN (Sore throat) in a 61-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 017B21A-0ED91421) for COVID-19 immunization.     Concomitant products included LEVETIRACETAM, CITALOPRAM, MULTIVITAMIN [VITAMINS NOS] and VITAMIN D3 for an unknown indication.    On 31-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 02-Apr-2021, the patient experienced INFLUENZA LIKE ILLNESS (Flu like symptoms (feel warm and hot, not fever nor) and OROPHARYNGEAL PAIN (Sore throat). At the time of the report, INFLUENZA LIKE ILLNESS (Flu like symptoms (feel warm and hot, not fever nor) and OROPHARYNGEAL PAIN (Sore throat) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Treatment information was not provided.
Age: 36.0
Sex: F
Vaccine: COVID19
Symptoms: Maternal exposure during pregnancy, Pregnancy test
Clinical narrative: Pregnancy; This spontaneous prospective pregnancy case was reported by a consumer and describes the occurrence of MATERNAL EXPOSURE DURING PREGNANCY (Pregnancy) in a 36-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 046A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 02-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1. The patient's last menstrual period was on 15-Nov-2020 and the estimated date of delivery was 13-Aug-2021. On 02-Apr-2021, the patient experienced MATERNAL EXPOSURE DURING PREGNANCY (Pregnancy). The patient received mRNA-1273 (Moderna COVID-19 Vaccine) beginning around the  nineteenth week of the pregnancy.  On 02-Apr-2021, MATERNAL EXPOSURE DURING PREGNANCY (Pregnancy) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 15-Dec-2020, Pregnancy test: Positive.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications reported by investigator No treatment medications provided.
Age: 57.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Cough, Headache
Clinical narrative: cough; chills; headache; This spontaneous case was reported by a consumer and describes the occurrence of COUGH (cough), CHILLS (chills) and HEADACHE (headache) in a 57-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 032M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 20-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 25-Mar-2021, the patient experienced COUGH (cough), CHILLS (chills) and HEADACHE (headache). The patient was treated with TRANEXAMIC ACID (TX) at an unspecified dose and frequency and CAFFEINE, CHLORPHENAMINE MALEATE, PARACETAMOL, PHENYLEPHRINE HYDROCHLORIDE (CORICIDIN F) at an unspecified dose and frequency. At the time of the report, COUGH (cough), CHILLS (chills) and HEADACHE (headache) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications reported.
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Fatigue, Feeling abnormal, Illness, Nausea
Clinical narrative: swelling; dizzy; sick; felt like dying; rash all over; fatigue; nausea; a burning fever; This spontaneous case was reported by a consumer and describes the occurrence of SWELLING (swelling), DIZZINESS (dizzy), ILLNESS (sick), FEELING ABNORMAL (felt like dying) and RASH (rash all over) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced SWELLING (swelling), DIZZINESS (dizzy), ILLNESS (sick), FEELING ABNORMAL (felt like dying), RASH (rash all over), FATIGUE (fatigue), NAUSEA (nausea) and PYREXIA (a burning fever). The patient was treated with IBUPROFEN ongoing since an unknown date at a dose of 1 dosage form and HYDROCORTISONE ongoing since an unknown date at a dose of 1 dosage form. At the time of the report, SWELLING (swelling), DIZZINESS (dizzy), ILLNESS (sick), FEELING ABNORMAL (felt like dying), RASH (rash all over), FATIGUE (fatigue), NAUSEA (nausea) and PYREXIA (a burning fever) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment medications also include other over-the-counter medicines to treat her symptoms. No concomitant product use was reported. Cross linked with case MOD21-068582. Caller is returning a call from safety.   Most recent FOLLOW-UP information incorporated above includes: On 17-Jun-2021: Follow up received on 17-JUN-2021.Non-significant follow-up. No new information was reported.
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia, Rash, Swelling
Clinical narrative: swelling; dizzy; sick; felt like dying; rash all over; fatigue; nausea; a burning fever; This spontaneous case was reported by a consumer and describes the occurrence of SWELLING (swelling), DIZZINESS (dizzy), ILLNESS (sick), FEELING ABNORMAL (felt like dying) and RASH (rash all over) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced SWELLING (swelling), DIZZINESS (dizzy), ILLNESS (sick), FEELING ABNORMAL (felt like dying), RASH (rash all over), FATIGUE (fatigue), NAUSEA (nausea) and PYREXIA (a burning fever). The patient was treated with IBUPROFEN ongoing since an unknown date at a dose of 1 dosage form and HYDROCORTISONE ongoing since an unknown date at a dose of 1 dosage form. At the time of the report, SWELLING (swelling), DIZZINESS (dizzy), ILLNESS (sick), FEELING ABNORMAL (felt like dying), RASH (rash all over), FATIGUE (fatigue), NAUSEA (nausea) and PYREXIA (a burning fever) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment medications also include other over-the-counter medicines to treat her symptoms. No concomitant product use was reported. Cross linked with case MOD21-068582. Caller is returning a call from safety.   Most recent FOLLOW-UP information incorporated above includes: On 17-Jun-2021: Follow up received on 17-JUN-2021.Non-significant follow-up. No new information was reported.
Sex: M
Vaccine: COVID19
Symptoms: Product administration error, Product temperature excursion issue
Clinical narrative: Vaccine administered after temperature excursion; Vaccine administered after temperature excursion; This spontaneous case was reported by a health care professional and describes the occurrence of PRODUCT ADMINISTRATION ERROR (Vaccine administered after temperature excursion) and PRODUCT TEMPERATURE EXCURSION ISSUE (Vaccine administered after temperature excursion) in a 19-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 003B21A) for COVID-19 vaccination.     The patient's past medical history included No adverse event (Medical history was not provided).    On 02-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form(s). On 02-Apr-2021, the patient experienced PRODUCT ADMINISTRATION ERROR (Vaccine administered after temperature excursion) and PRODUCT TEMPERATURE EXCURSION ISSUE (Vaccine administered after temperature excursion). On 02-Apr-2021, PRODUCT ADMINISTRATION ERROR (Vaccine administered after temperature excursion) and PRODUCT TEMPERATURE EXCURSION ISSUE (Vaccine administered after temperature excursion) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   HCP reported on 02Apr2021 that they had power outage on 02Apr2021 and vials were in freezer and refrigerator where temperature dropped to : Frozen Vaccine 47Minutes -13.79 C, Refrigerator 59 Minutes 12 C and effected vials are: Lot no 003B21A, 100 doses, Lot no 027B21A 100 doses, Lot no 030B21A 100 doses and Lot No 02B21A 140 doses
Age: 62.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Myalgia, Pyrexia
Clinical narrative: Sore muscles, joints; Feeling feverish; Sore muscles, joints; This spontaneous case was reported by a consumer and describes the occurrence of ARTHRALGIA (Sore muscles, joints), PYREXIA (Feeling feverish) and MYALGIA (Sore muscles, joints) in a 62-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced ARTHRALGIA (Sore muscles, joints), PYREXIA (Feeling feverish) and MYALGIA (Sore muscles, joints). At the time of the report, ARTHRALGIA (Sore muscles, joints), PYREXIA (Feeling feverish) and MYALGIA (Sore muscles, joints) outcome was unknown.            No relevant concomitant medications were reported. No treatment information was provided.
Age: 30.0
Sex: M
Vaccine: COVID19
Symptoms: Fatigue, Hyperhidrosis, Pain, Paraesthesia, Vomiting
Clinical narrative: His arm was tingling immediately after; He woke up in the middle of the night sweating; Body aches; Vomited; He was feeling fatigue; This spontaneous case was reported by a consumer and describes the occurrence of PARAESTHESIA (His arm was tingling immediately after), HYPERHIDROSIS (He woke up in the middle of the night sweating), PAIN (Body aches), VOMITING (Vomited) and FATIGUE (He was feeling fatigue) in a 30-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 003B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 01-Apr-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 01-Apr-2021, the patient experienced PARAESTHESIA (His arm was tingling immediately after), HYPERHIDROSIS (He woke up in the middle of the night sweating), PAIN (Body aches), VOMITING (Vomited) and FATIGUE (He was feeling fatigue). At the time of the report, PARAESTHESIA (His arm was tingling immediately after), HYPERHIDROSIS (He woke up in the middle of the night sweating), PAIN (Body aches), VOMITING (Vomited) and FATIGUE (He was feeling fatigue) had resolved.            No relevant concomitant medications were reported. No treatment information was provided.   Most recent FOLLOW-UP information incorporated above includes: On 16-Jun-2021: Follow up information was received on 16-Jun-2021. The outcome of the events Body aches, fatigue, night sweating, arm tingling immediately and Vomiting was updated to recovered. Narrative updated.
Sex: F
Vaccine: COVID19
Symptoms: Antibody test, Antibody test negative
Clinical narrative: IgG test came back negative; This spontaneous case was reported by a consumer and describes the occurrence of ANTIBODY TEST NEGATIVE (IgG test came back negative) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 14-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 14-Feb-2021, the patient experienced ANTIBODY TEST NEGATIVE (IgG test came back negative). At the time of the report, ANTIBODY TEST NEGATIVE (IgG test came back negative) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 14-Feb-2021, Antibody test: negative (Negative) IgG test came back negative.         No relevant concomitant medications were reported. No treatment information was provided. Action taken with mRNA-1273 in response to the events was not applicable.   Most recent FOLLOW-UP information incorporated above includes: On 16-Jun-2021: Follow up information was received on 16-Jun-2021: contains no new information.
Age: 37.0
Sex: F
Vaccine: COVID19
Symptoms: Back pain, Chills, Fatigue, Myalgia, Pyrexia
Clinical narrative: Backache; Fever; Muscle pain; Chills; Fatigued; This spontaneous case was reported by a consumer and describes the occurrence of BACK PAIN (Backache), PYREXIA (Fever), MYALGIA (Muscle pain), CHILLS (Chills) and FATIGUE (Fatigued) in a 37-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 016B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 30-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 30-Mar-2021, the patient experienced BACK PAIN (Backache), PYREXIA (Fever), MYALGIA (Muscle pain), CHILLS (Chills) and FATIGUE (Fatigued). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, BACK PAIN (Backache), PYREXIA (Fever), MYALGIA (Muscle pain), CHILLS (Chills) and FATIGUE (Fatigued) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were reported.
Age: 53.0
Sex: F
Vaccine: COVID19
Symptoms: Product temperature excursion issue
Clinical narrative: Vaccine administered after temperature excursion; This spontaneous case was reported by an other health care professional and describes the occurrence of PRODUCT TEMPERATURE EXCURSION ISSUE (Vaccine administered after temperature excursion) in a 53-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 003B21A) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 02-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 02-Apr-2021, the patient experienced PRODUCT TEMPERATURE EXCURSION ISSUE (Vaccine administered after temperature excursion). At the time of the report, PRODUCT TEMPERATURE EXCURSION ISSUE (Vaccine administered after temperature excursion) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   relevant concomitant products usage were not reported by the reporter.treatment details not included.
Age: 16.0
Sex: F
Vaccine: COVID19
Symptoms: Decreased appetite, Product administered to patient of inappropriate age, Pyrexia
Clinical narrative: Decreased appetite; 16 year old patient was accidentally administered the 1st Moderna Vaccination; Developed low grade fever; This spontaneous case was reported by a nurse (subsequently medically confirmed) and describes the occurrence of DECREASED APPETITE (Decreased appetite), PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (16 year old patient was accidentally administered the 1st Moderna Vaccination) and PYREXIA (Developed low grade fever) in a 16-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025A21A) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No reported medical history).    On 30-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 30-Mar-2021, the patient experienced DECREASED APPETITE (Decreased appetite), PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (16 year old patient was accidentally administered the 1st Moderna Vaccination) and PYREXIA (Developed low grade fever). On 30-Mar-2021, PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (16 year old patient was accidentally administered the 1st Moderna Vaccination) had resolved. At the time of the report, DECREASED APPETITE (Decreased appetite) and PYREXIA (Developed low grade fever) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant product use was not provided by the reporter.  Treatment information was not provided.  Very limited information regarding this events has been provided at this time. Further information has been requested. Company assessed the events to be unlikely related to company product.; Sender's Comments: Very limited information regarding this events has been provided at this time. Further information has been requested. Company assessed the events to be unlikely related to company product.
Age: 76.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: Sore arm; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Sore arm) in a 76-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011A21A) for COVID-19 vaccination.     The patient's past medical history included No adverse event.   On 04-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (Sore arm). At the time of the report, PAIN IN EXTREMITY (Sore arm) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Action taken with mRNA-1273 in response to the events was not Applicable.  Concomitant product use was not provided by the reporter. Treatment information was not provided.   This case was linked to MOD-2021-066334 (Patient Link).
Age: 56.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Cough, Nasal congestion, Rhinorrhoea, Throat irritation
Clinical narrative: Positive COVID test; Congestion; Cough; Nasal drip; Scratchy throat; This spontaneous case was reported by a consumer and describes the occurrence of THROAT IRRITATION (Scratchy throat), COVID-19 (Positive COVID test), NASAL CONGESTION (Congestion), COUGH (Cough) and RHINORRHOEA (Nasal drip) in a 56-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 038A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 20-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 22-Mar-2021, the patient experienced THROAT IRRITATION (Scratchy throat), NASAL CONGESTION (Congestion), COUGH (Cough) and RHINORRHOEA (Nasal drip). On 27-Mar-2021, the patient experienced COVID-19 (Positive COVID test). The patient was treated with CHLORPHENAMINE MALEATE, PARACETAMOL (CORICIDIN [CHLORPHENAMINE MALEATE;PARACETAMOL]) at an unspecified dose and frequency. At the time of the report, THROAT IRRITATION (Scratchy throat), COVID-19 (Positive COVID test), NASAL CONGESTION (Congestion), COUGH (Cough) and RHINORRHOEA (Nasal drip) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No relevant concomitant medications were reported.
Age: 74.0
Sex: M
Vaccine: COVID19
Symptoms: Flushing
Clinical narrative: Flushing of the face; This spontaneous case was reported by a physician and describes the occurrence of FLUSHING (Flushing of the face) in a 74-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 001B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 11-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 11-Mar-2021, the patient experienced FLUSHING (Flushing of the face). On 14-Mar-2021, FLUSHING (Flushing of the face) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Relevant concomitant products usage were not reported by the reporter.  Treatment details were not included.  Based on the current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded.
Age: 32.0
Sex: F
Vaccine: COVID19
Symptoms: Lymph node pain, Paraesthesia
Clinical narrative: This spontaneous case reported by a healthcare professional, describes the occurrence of paresthesia (now her finger is tingling) and lymph node pain (pain in her lymph node, which then moved into her right arm) in a 32-year-old female patient who received mRNA-1273 (Moderna COVID-19 vaccine) for COVID-19 immunization. No medical history reported. On an unknown date, patient received the second dose of mRNA-1273 (Moderna COVID-19 vaccine), unknown route; 1 dosage form. On Apr 1, 2021, patient experienced paresthesia (now her finger is tingling) and  lymph node pain (pain in her lymph node, which then moved into her right arm). At the time of the report, paresthesia (now her finger is tingling) and lymph node pain (pain in her lymph node, which then moved into her right arm) outcome: unknown. The action taken with mRNA-1273 (Moderna COVID-19 vaccine), intramuscular: unknown. The reporter did not provide any causality assessments, concomitant medication or treatment medication.
Age: 76.0
Sex: M
Vaccine: COVID19
Symptoms: Dizziness, Pruritus, Rash
Clinical narrative: itchy all over the body; Rash all over the body; Dizziness; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (Dizziness), PRURITUS (itchy all over the body) and RASH (Rash all over the body) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 29-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 02-Apr-2021, the patient experienced DIZZINESS (Dizziness) and RASH (Rash all over the body). On an unknown date, the patient experienced PRURITUS (itchy all over the body). At the time of the report, DIZZINESS (Dizziness), PRURITUS (itchy all over the body) and RASH (Rash all over the body) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 33.0
Sex: M
Vaccine: COVID19
Symptoms: Product temperature excursion issue
Clinical narrative: Vaccine administered after temperature excursion; This spontaneous case was reported by a physician and describes the occurrence of PRODUCT TEMPERATURE EXCURSION ISSUE (Vaccine administered after temperature excursion) in a 33-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 003B21A) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 02-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 02-Apr-2021, the patient experienced PRODUCT TEMPERATURE EXCURSION ISSUE (Vaccine administered after temperature excursion). At the time of the report, PRODUCT TEMPERATURE EXCURSION ISSUE (Vaccine administered after temperature excursion) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   relevant concomitant products usage were not reported by the reporter.treatment details not included.
Age: 60.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: ring finger felt like slammed in door; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (ring finger felt like slammed in door) in a 60-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 01-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 01-Apr-2021, the patient experienced PAIN IN EXTREMITY (ring finger felt like slammed in door). At the time of the report, PAIN IN EXTREMITY (ring finger felt like slammed in door) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant product use was not provided by the reporter. Treatment information was not provided.
Age: 68.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Erythema, Illness, Nausea, Pain in extremity
Clinical narrative: Sick; Dizziness; Arm red and sore; Arm red and sore; Feel nauseous; This spontaneous case was reported by a consumer and describes the occurrence of ILLNESS (Sick), DIZZINESS (Dizziness), ERYTHEMA (Arm red and sore), PAIN IN EXTREMITY (Arm red and sore) and NAUSEA (Feel nauseous) in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 046A21A) for COVID-19 vaccination.     No Medical History information was reported.   On 03-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 31-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 01-Apr-2021, the patient experienced ILLNESS (Sick), DIZZINESS (Dizziness), ERYTHEMA (Arm red and sore), PAIN IN EXTREMITY (Arm red and sore) and NAUSEA (Feel nauseous). At the time of the report, ILLNESS (Sick), DIZZINESS (Dizziness), ERYTHEMA (Arm red and sore), PAIN IN EXTREMITY (Arm red and sore) and NAUSEA (Feel nauseous) outcome was unknown.            No relevant concomitant medications were reported. No treatment information was provided.
Age: 69.0
Sex: M
Vaccine: COVID19
Symptoms: Dizziness, Feeling abnormal, Gait disturbance, Limb discomfort, Musculoskeletal stiffness
Clinical narrative: is really messed up and never felt like this before and feeling so bad; blurry vision; neck is so stiff now; left shoulder is blueish; left arm pain; legs feel like dead weights; he can hardly walk at all; unbelievable extreme dizziness; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (unbelievable extreme dizziness), FEELING ABNORMAL (is really messed up and never felt like this before and feeling so bad), VISION BLURRED (blurry vision), MUSCULOSKELETAL STIFFNESS (neck is so stiff now) and SKIN DISCOLOURATION (left shoulder is blueish) in a 69-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 01-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 01-Apr-2021, the patient experienced DIZZINESS (unbelievable extreme dizziness). On an unknown date, the patient experienced FEELING ABNORMAL (is really messed up and never felt like this before and feeling so bad), VISION BLURRED (blurry vision), MUSCULOSKELETAL STIFFNESS (neck is so stiff now), SKIN DISCOLOURATION (left shoulder is blueish), PAIN IN EXTREMITY (left arm pain), LIMB DISCOMFORT (legs feel like dead weights) and GAIT DISTURBANCE (he can hardly walk at all). At the time of the report, DIZZINESS (unbelievable extreme dizziness), FEELING ABNORMAL (is really messed up and never felt like this before and feeling so bad), VISION BLURRED (blurry vision), MUSCULOSKELETAL STIFFNESS (neck is so stiff now), SKIN DISCOLOURATION (left shoulder is blueish), PAIN IN EXTREMITY (left arm pain), LIMB DISCOMFORT (legs feel like dead weights) and GAIT DISTURBANCE (he can hardly walk at all) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant product use was not provided by the reporter.  He had taken two aspirin for his arm pain.   This case was linked to US-MODERNATX, INC.-MOD-2021-090270 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-090270:dose 1